Induction of IW32 erythroleukemia cell differentiation by p53 is dependent on protein tyrosine phosphatase

Leukemia

Volumn 14, Issue 7, 2000, Pages 1292-1300

  Tang, P P ^a   Wang, F F ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Differentiation; Erythroleukemia; P53; Protein tyrosine phosphatase

Indexed keywords

5 AMINOLEVULINATE SYNTHASE; BENZIDINE; BETA GLOBIN; COMPLEMENTARY DNA; MESSENGER RNA; PROTEIN P53; PROTEIN TYROSINE PHOSPHATASE; VANADIC ACID;

ALLELE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CLONE; CELL CYCLE G1 PHASE; CELL DEATH; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROLEUKEMIA CELL; GENETIC TRANSFECTION; GROWTH INHIBITION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TEMPERATURE SENSITIVE MUTANT;

EID: 0033921049     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401823     Document Type: Article

References (45)

1. Pfeifer GP, Holmquist GP. Mutagenesis in the p53 gene. Biochim Biophys Acta 1997; 1333: M1-M8.
2. Lane DP. p53, guardian of the genome. Nature 1992; 358: 15-16.
3. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997; 88: 323-331.
4. Maltzman W, Czyzyk L. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol Cell Biol 1984; 4: 1689-1694.
5. Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 1992; 89: 7491-7495.
6. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991; 51: 6304-6311.
7. Woo RA, McLure KG, Lees-Miller SP, Rancourt DE, Lee PW. DNA-dependent protein kinase acts upstream of p53 in response to DNA damage. Nature 1998; 394: 700-704.
8. Nakagawa K, Taya Y, Tamai K, Yamaizumi M. Requirement of ATM in phosphorylation of the human p53 protein at serine 15 following DNA double-strand breaks. Mol Cell Biol 1999; 19: 2828-2834.
9. 1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes Dev 1996; 10: 934-947.
10. Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerda RL, Raskind WH, Reid BJ. A p53-dependent mouse spindle checkpoint. Science 1995; 267: 1353-1356.
11. Almog N, Rotter V. Involvement of p53 in cell differentiation and development. Biochim Biophys Acta 1997; 1333: F1-F27.
12. Kastan MB, Radin AI, Kuerbitz SJ, Onyekwere O, Wolkow CA, Civin CI, Stone KD, Woo T, Ravindranath Y, Craig RW. Levels of p53 protein increase with maturation in human hematopoietic cells. Cancer Res 1991; 51: 4279-4286.
13. Feinstein E, Gale RP, Reed J, Canaani E. Expression of the normal p53 gene induces differentiation of K562 cells. Oncogene 1992; 7: 1853-1857.
14. Soddu S, Blandino G, Citro G, Scardigli R, Piaggio G, Ferber A, Calabretta B, Sacchi A. Wild-type p53 gene expression induces granulocytic differentiation of HL-60 cells. Blood 1994; 83: 2230-2237.
15. Johnson P, Chung S, Benchimol S. Growth suppression of Friend virus-transformed erythroleukemia cells by p53 protein is accompanied by hemoglobin production and is sensitive to erythropoietin. Mol Cell Biol 1993; 13: 1456-1463.
16. WAF1 regulates neuronal differentiation of PC12 cells. J Biol Chem 1997; 272: 24002-24007.
17. Lang D, Miknyoczki SJ, Huang L, Ruggeri BA. Stable reintroduction of wild-type p53 (MTmp53ts) causes the induction of apoptosis and neuroendocrine-like differentiation in human ductal pancreatic carcinoma cells. Oncogene 1998; 16: 1593-1602.
18. Eizenberg O, Faber-Elman A, Gottlieb E, Oren M, Rotter V, Schwartz M. p53 plays a regulatory role in differentiation and apoptosis of central nervous system-associated cells. Mol Cell Biol 1996; 16: 5178-5185.
19. Soddu S, Blandino G, Scardigli R, Coen S, Marchetti A, Rizzo MG, Bossi G, Cimino L, Crescenzi M, Sacchi A. Interference with p53 protein inhibits hematopoietic and muscle differentiation. J Cell Biol 1996; 134: 193-204.
20. Tamir Y, Bengal E. p53 protein is activated during muscle differentiation and participates with MyoD in the transcription of muscle creatine kinase gene. Oncogene 1998; 17: 347-356.
21. Donehower LA, Harvey M, Slagle BL, McArthur MI, Montgomery CA Jr, Butel JS, Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992; 356: 215-221.
22. Cho I, Donehowe LA. p53 in embryonic development: maintaining a fine balance. Cell Mol Life Sci 1999; 55: 38-47.
23. Pan H, Griep AE. Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppresses gene function in development. Genes Dev 1994; 8: 1285-1299.
24. Pan H, Griep AE. Temporally distinct patterns of p53-dependent and p53-independent apoptosis during mouse lens development. Genes DPV 1995; 9: 2157-2169.
25. Gottlieb E, Oren M. p53 facilitates pRb cleavage in IL-3-deprived cells: novel pro-apoptotic activity of p53. EMBO J 1998; 17: 3587-3596.
26. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 1991; 352: 345-347.
27. Helps NR, Barker HM, Elledge SJ, Cohen PTW. Protein phosphatase 1 interacts with p53BP2, a protein which binds to the tumour suppressor p53. FEBS Lett 1995; 377: 295-300.
28. Fiscella M, Zhang H, Fan S, Sakaguchi K, Shen S, Mercer WE, Vande Woude G F, O'Connor PM, Appella E. Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. Proc Natl Acad Sci USA 1997; 94: 6048-6053.
29. Okamoto K, Kamibayashi C, Serrano M, Prives C, Mumby MC, Beach D. p53-dependent association between cyclin G and the B subunit of protein phosphatase 2A. Mol Cell Biol 1996; 16: 6593-6602.
30. Kume T, Tsuneizumi K, Watanabe T, Thomas ML, Oishi M. Induction of specific protein tyrosine phosphatase transcripts during differentiation of mouse erythroleukemia cells. J Biol Chem 1996; 269: 4709-4712.
31. Kumt T, Watanabe T, Sanokawo R, Chida D, Nakamura T, Oishi M. Expression of the protein tyrosine phosphatase β2 gene in mouse erythroleukemia cells induces terminal erythroid differentiation. J Biol Chem 1996; 271: 30916-30921.
32. LaMontagne KR Jr, Hannon C, Tonks NK. Protein tyrosine phosphatase PTP1 B suppresses p210 bcr-abl-induced transformation of rat-1 fibroblasts and promotes differentiation of K562 cells. Proc Natl Acad Sci USA 1998; 95: 14094-14099.
33. Aoki N, Yamaguchi-Aoki Y, Ullrich A. The novel protein-tyrosine phosphatase PTP20 is a positive regulator of PC12 cell neuronal differentiation. J Biol Chem 1996; 271: 29422-29426.
34. Wang MC, Liu JH, Wang FF. Protein tyrosine phosphatase-dependent activation of β-globin and δ-aminolevulinic acid synthase genes in thecamptothecin-induced IW32 erythroleukemia cell differentiation. Mol Pharmacol 1997; 51: 558-566.
35. Michalovitz D, Halevy O, Oren M. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell 1990; 62: 671-680.
36. Choppin J, Lacombe C, Casadevall N, Muller O, Tambourin P, Varet B. Characterization of erythropoietin produced by IW32 murine erythroleukemia cells. Blood 1984; 64: 341-347.
37. Orkin SH, Harosi FI, Leder P. Differentiation in erythroleukemic cells and their somatic hybrids. Proc Natl Acid Sci USA 1975; 72: 98-102.
38. El-Deiry WS, Tokono T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75: 817-825.
39. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activartor of the human bax gene. Cell 1995; 80: 293-299.
40. Ronen D, Schwartz D, Teitz Y, Goldfinger N, Rotter V. Induction of HL-60 cells to undergo apoptosis is determined by high levels of wild-type p53 protein whereas differentiation of the cells is mediated by lower p53 levels. Cell Growth Differ 1996; 7: 21-30.
41. Ehinger M, Bergh G, Johnsson E, Gullberg U, Olsson I. The tumor suppressor gene p53 can mediate transforming the growth factor β1-induced differentiation of leukemic cells independently of activation of the retinoblastoma protein. Cell Growth Differ 1997; 8: 1127-1137.
42. Ehinger M, Bergh G, Johnsson E, Baldetorp B, Olsson I, Gullberg U. p53-dependent and -independent differentiation of leukemic U-937 cells: relationship to cell cycle control. Exp Hematol 1998; 26: 1043-1052.
43. Friedman SL, Shaulian E, Littlewood T, Resnitzky D, Oren M. Resistance to p53-mediated growth arrest and apoptosis in Hep 3B hepatoma cells. Oncogene 1997; 15: 63-70.
44. Giaccia AJ, Kastan MB. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev 1998; 12: 2973-2983.
45. Tanuma N, Nakamura K, Kikuchi K. Distinct promoters control transmembrane and cytosolic protein tyrosine phosphatase ε expression during macrophage differentiation. Eur J Biochem 1999; 259: 46-54.